https://pharminent.com/market-access/market-access-intelligence-weekly-digest-july-17-2026/ 2026-07-17T21:46:49Z Pharminent en MARKET ACCESS INTELLIGENCE • Weekly Digest • July 17, 2026 2026-07-17T21:46:47Z Blog https://pharminent.com/fda-converts-novartis-fabhalta-to-full-approval-in-iga-nephropathy/ 2026-07-17T21:12:31Z Pharminent en FDA Converts Novartis' Fabhalta to Full Approval in IgA Nephropathy 2026-07-17T20:31:45Z Blog https://pharminent.com/novo-lands-european-oral-wegovy-approval-before-lilly-can-respond/ 2026-07-17T20:31:42Z Pharminent en Novo Lands European Oral Wegovy Approval Before Lilly Can Respond 2026-07-17T20:31:42Z Blog https://pharminent.com/glp-1-competitive-market/glp-1-competitive-market-digest-weekly-july-17-2026/ 2026-07-17T20:12:12Z Pharminent en GLP-1 Competitive Market Digest • Weekly • July 17, 2026 2026-07-17T20:12:10Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-july-16-2026/ 2026-07-17T16:05:27Z Pharminent en Rare Disease & Gene Therapy Digest • July 16, 2026 2026-07-17T16:05:25Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-july-17-2026/ 2026-07-17T15:53:16Z Pharminent en Strategic News Watch • July 17, 2026 2026-07-17T15:53:14Z Blog https://pharminent.com/merck-wins-first-fda-approval-of-an-oral-pcsk9-inhibitor-with-cholesterol-pill-lipfendra/ 2026-07-16T23:42:59Z Pharminent en Merck Wins First FDA Approval of an Oral PCSK9 Inhibitor with Cholesterol Pill Lipfendra 2026-07-16T20:22:35Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-july-16-2026/ 2026-07-16T15:49:46Z Pharminent en Strategic News Watch • July 16, 2026 2026-07-16T15:49:43Z Blog https://pharminent.com/fda-approves-at-home-leqembi-for-early-alzheimers-disease/ 2026-07-16T20:36:04Z Pharminent en FDA Approves At-Home Leqembi for Early Alzheimer's Disease 2026-07-16T14:37:44Z Blog https://pharminent.com/lilly-enters-psychedelic-realm-through-2-8bn-ataibeckley-takeover/ 2026-07-17T14:34:14Z Pharminent en Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover 2026-07-16T13:34:47Z Blog https://pharminent.com/neuromarket-pulse/neuromarket-pulse-weekly-neuroscience-competitive-intelligence-july-8-2026/ 2026-07-16T12:14:30Z Pharminent en NeuroMarket Pulse • Weekly Neuroscience Competitive Intelligence • July 8, 2026 2026-07-16T12:14:28Z Blog